Health Condition 1: O359- Maternal care for (suspected) fetal abnormality and damage, unspecified
Conditions
Interventions
Intervention1: Mifepristone with standard treatment of Misoprostol for inducing labour in Intrauterine death: Mifepristone (RU-486) is an antiprogesterone drug which binds to progesterone receptor wit
Sponsors
Government Institute of Medical SciencesGreater Noida Gautam Buddha Nagar UP
Eligibility
Inclusion criteria
Inclusion criteria: A. Inclusion criteria : Confirmed IUD Singleton pregnancy Cephalic presentation Bishops score Previous normal vaginal deliveries No cephalopelvic disproportion
Exclusion criteria
Exclusion criteria: Grand Multipara Previous LSCS Pre eclampsia Abruption PROM, Sepsis DIC Contraindications to mifepristone & misoprostol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| induction to delivery interval (interval between first dose of misoprostol and delivery).Timepoint: induction to delivery interval (interval between first dose of misoprostol and delivery). | — |
Secondary
| Measure | Time frame |
|---|---|
| mode of deliveryTimepoint: vaginal or cesarean;adverse effectsTimepoint: nausea, vomiting, diarrhea, fever, shivering;change in the Bishops score, change in the Bishops scoreTimepoint: 6-13 in 24 hours or less;number of doses of misoprostol requiredTimepoint: 0-5 doses;requirement of oxytocinTimepoint: mIU/ml | — |
Countries
India
Contacts
Public ContactDr Ritu Sharma
Government Institute of Medical Sciences, Greater Noida
Outcome results
None listed